Cargando…
Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study
BACKGROUND: Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. Given the chronic and heterogenous nature of the disease, treatment with various therapies is a frequent scenario in clinical practice. In persons with chronic morbidity such as MS patients, polypharmacy...
Autores principales: | Frahm, Niklas, Hecker, Michael, Zettl, Uwe Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345436/ https://www.ncbi.nlm.nih.gov/pubmed/30677078 http://dx.doi.org/10.1371/journal.pone.0211120 |
Ejemplares similares
-
Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
por: Frahm, Niklas, et al.
Publicado: (2019) -
The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020) -
Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023) -
Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022) -
Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors
por: Frahm, Niklas, et al.
Publicado: (2019)